Loading...
Patients with Philadelphia-Positive Leukemia with BCR-ABL Kinase Mutations Prior to Allogeneic Transplantation Predominantly Relapse with the Same Mutation
Despite the successes of tyrosine kinase inhibitors (TKIs) in improving outcomes in patients with chronic myeloid leukemia (CML) and Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL), allogeneic hematopoietic stem cell transplantation (HSCT) continues to be an important and potentially cu...
Na minha lista:
| Udgivet i: | Biol Blood Marrow Transplant |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4464836/ https://ncbi.nlm.nih.gov/pubmed/25300870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.09.012 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|